Close Menu
Home › Lucid Diagnostics Licenses Barrett's Esophagus Biomarker Tech from CWRU

Lucid Diagnostics Licenses Barrett's Esophagus Biomarker Tech from CWRU

May 14, 2018
|
staff reporter

NEW YORK (GenomeWeb) – PavMed announced today that it has completed a definitive licensing agreement with Case Western Reserve University to develop and commercialize CWRU's EsoCheck technology.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jan
28
Featured Webinar

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of FLT3 and CEBPA

Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

Feb
05
Featured Webinar

Development of a Novel Multiplex Assay: A Partnership Case Study

Sponsored by
LGC

This webinar will provide a behind-the-scenes look at the collaborative development of a novel multiplex assay to speed detection of mosquito-borne illness in the clinical setting.

What's Popular?

In Molecular Diagnostics

  1. Diagnostics Developers Leap Into Action on Novel Coronavirus Tests

    Premium

  2. Adaptive Biotechnologies Prices Public Offering of Stock

  3. Quest Diagnostics Acquires Blueprint Genetics

  4. Myriad Genetics Seeks Supplemental Approval of HRD Test as CDx for GSK Ovarian Cancer Drug

  5. Ontera Developing Single-Pore Sensor for Sepsis, TB, and Zika Diagnostic Testing

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.